Patents Assigned to GLYCA INC.
  • Methods for diagnosing high-risk cancer using polysialic acid and one or more tissue-specific biomarkers
    Patent number: 11448650
    Abstract: Described herein are methods for diagnosing high-risk cancer in a subject by detecting PolySialic Acid (polySia) in a biological sample obtained from the subject, or by detecting polySia and one or more tissue-specific markers in a biological sample obtained from the subject.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: September 20, 2022
    Assignee: GLYCA INC.
    Inventors: Karla Williams, Hon Sing Leong